Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Satellos Bioscience Inc. (T.MSL) had Consolidated Net Income/Loss of -0.33M for the most recently reported fiscal quarter, ending 2018-03-31.
| Income Statement Financials | |
-- |
|
-0.33M |
|
-- |
|
-- |
|
-- |
|
-0.45M |
|
-- |
|
-0.33M |
|
-0.33M |
|
-0.33M |
|
-0.33M |
|
|
Consolidated Net Income/Loss |
-0.33M |
-0.33M |
|
-0.45M |
|
-0.45M |
|
4.22M |
|
4.22M |
|
0.00 |
|
0.00 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
0.70M |
|
-- |
|
-- |
|
-- |
|
0.17M |
|
0.53M |
|
0.53M |
|
0.53M |
|
4.22M |
|
| Cash Flow Statement Financials | |
-0.39M |
|
-- |
|
-- |
|
0.89M |
|
0.50M |
|
-0.39M |
|
0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-0.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-62.02% |
|
-61.83% |
|
-47.17% |
|
-61.83% |
|
0.16 |
|
-0.09 |
|
-0.09 |
|